Researchers from Medical University of Innsbruck Report Findings in Cardiovascular Diseases and Conditions

2020 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Disease Prevention Daily -- Investigators publish new report on Cardiovascular Diseases and Conditions. According to news reporting originating in Innsbruck, Austria, by NewsRx journalists, research stated, “According to the World Health Organization, cardiovascular diseases (CVDs) are the leading non-communicable cause of death. Awareness of the individual risk profile is crucial to implement a healthy lifestyle and prevent CVDs.”

Financial support for this research came from Competence centers for excellent techologies - Comet.

The news reporters obtained a quote from the research from the Medical University of Innsbruck, “Multiple studies demonstrated that atherosclerosis, the main cause of CVDs, begins early in life. Therefore, it may be necessary to start prevention programs already in childhood. The EVA-Tyrol study is a population-based non-randomized controlled trial that will prospectively enroll 2000 participants from high schools and training companies in North-and East-Tyrol (Austria) and South-Tyrol (Italy). Participants will be assigned to either an intervention (n=1500) or a control (n=500) group. Intervention group participants will be enrolled at the 10th school grade (mean age 15-16 years), undergo two examinations within a two-year interval, with follow-up at the 12th grade (mean ages 17-18 years). Control group participants will be enrolled at the 12th grade (mean age 17-18 years). Medical examination will include anthropometric measurements, comprehensive lifestyle and dietary questionnaires, a fasting blood sample, high-resolution ultrasound of the carotid arteries, and measurement of carotid-femoral pulse wave velocity. Active intervention will consist of (1) enhancing knowledge about CVDs, (2) individual medical counseling based on the results of the baseline examination, (3) an online health promotion tool and (4) involvement of participants in planning and implementation of health promotion projects. Effectiveness of the intervention will be assessed by comparing the proportion subjects with ideal health metrics as defined by the American Heart Association between study groups. This study aims to improve cardiovascular health in Tyrolean adolescents by demonstrating the efficacy of a multi-layer health promotion program and may yield novel insights into the prevalence of vascular risk conditions and mechanisms of early vascular pathologies in adolescents.”

According to the news reporters, the research concluded: “EVA-Tyrol has been retrospectively registered at clinicaltrials.gov under NCT03929692 since April 29,.”

For more information on this research see: The Tyrolean early vascular ageing-study (EVA-Tyrol): study protocol for a non-randomized controlled trial : Effect of a cardiovascular health promotion program in youth, a prospective cohort study. Bmc Cardiovascular Disorders, 2020;20(1):59. (BioMed Central - http://www.biomedcentral.com/; Bmc Cardiovascular Disorders - http://www.biomedcentral.com/bmccardiovascdisord/)

Our news correspondents report that additional information may be obtained by contacting N. Gande, Dept. of Pediatrics II, Medical University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria. Additional authors for this research include B. Bernar, K.A. Stock, A. Staudt, R. Pechlaner, R. Geiger, A. Griesmacher, S. Kiechl, M. Knoflach and U. Kiechl-Kohlendorfer.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1186/s12872-020-01357-9. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)